The Illumina Illumina Institute announced that it has launched a $1.6 billion, five-year plan to sequence and analyze all of the human genome.
This includes all of its Illumina sequencers, which are already in use in some of the world’s most advanced sequencing labs.
However, Illumina said it wants to continue its work in other areas, including biosafety and bioinformatics.
The Illumina announcement was made during the company’s annual shareholder meeting.
While it will be interesting to see how much money is left over after this initial launch, Illumine is aiming to be the largest company in the world to sequence all of our genomes.
It will be able to sequence more than 100 million genomes, which is about twice as many as the average commercial sequencing lab.
The company is also expanding its sequencing efforts.
Last year, it started using a new technique called Illumina Hybrid Nucleic Acid, which uses nucleic acids from other companies to improve its performance and lower the cost of sequencing.
This will also be incorporated into future generations of Illumina Sequencing kits.
The company has already started to work with the company of Japanese scientists to get the same technology used in the new Illumina kit.
The technology can be used to sequence a large number of genes at once, which Illumina hopes will help it to scale its commercial sequencing capabilities.
The technology also promises to help the company in other ways.
The Illumine Illumina team has created a new way to analyze the genomes of the animals it has been studying, in addition to studying human genes.
This allows it to compare genetic variants that occur in the animals with those in humans.
The researchers believe the technology could also be used for studying the effects of drugs on genes.
This technology is still very early in development, so the company is still exploring its use in the next generation of human genetic sequencing.
However the company hopes to be able use it in human clinical trials within the next five years.
The goal is to eventually have all human genomes sequenced by 2020.
Follow Erik Verducci on Twitter.